Medicare Enrolled

Dr. James Teasdall

Urology Physician · Raleigh, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3821 ED DR, Raleigh, NC 27612
9842628026
In practice since 2021 (4 years)
NPI: 1881357796 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Teasdall from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Teasdall? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Teasdall

Dr. James Teasdall is an urology physician in Raleigh, NC, with 4 years of NPI registration. Based on federal Medicare data, Dr. Teasdall performed 3,799 Medicare services across 2,080 unique beneficiaries.

Between the years covered by Open Payments, Dr. Teasdall received a total of $2,671 from 30 pharmaceutical and/or device companies across 121 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Teasdall is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 4 years in practice ▲ Top 23% volume in NC $2,671 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,799
Medicare services
Top 23% in NC for urology physician
2,080
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~950 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
1,200 $0 $10
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
533 $5 $19
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
357 $49 $125
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
328 $72 $209
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
309 $2 $8
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
273 $7 $35
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
272 $3 $12
PSA test (prostate cancer screening) 146 $18 $68
Abdominal X-ray, 1 view
An X-ray image of the abdomen taken from a single angle to visualize internal structures.
86 $14 $51
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
52 $50 $120
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
37 $80 $200
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
35 $25 $96
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
28 $67 $180
CT scan of abdomen and pelvis, without contrast
A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye.
25 $76 $250
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
24 $53 $219
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
19 $48 $213
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $31 $75
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
16 $32 $185
CT scan of abdomen and pelvis with contrast
A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures.
14 $189 $895
Blood creatinine level test
A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function.
14 $5 $19
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
13 $13 $35
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,671
Total received (2021-2024)
Avg $668/year across 4 years
Top 48% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
121
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,606 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$65 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$771
2023
$820
2022
$993
2021
$87

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$235
Dendreon Pharmaceuticals LLC
$193
PFIZER INC.
$84
Merck Sharp & Dohme LLC
$67
Blue Earth Diagnostics Limited
$61
ABBVIE INC.
$38
Endo USA, Inc.
$37
Endo Pharmaceuticals Inc.
$20
CIVCO Medical Instruments
$19
PROGENICS PHARMACEUTICALS, INC.
$17
Top 3 companies account for 66.3% of 2024 payments
All-time payments by company (2021-2024) ›
Dendreon Pharmaceuticals LLC
$513
Sumitomo Pharma America, Inc.
$401
PFIZER INC.
$202
ABBVIE INC.
$173
Blue Earth Diagnostics Limited
$168
GENZYME CORPORATION
$138
UROVANT SCIENCES INC
$135
Teleflex LLC
$135
Endo Pharmaceuticals Inc.
$97
Merck Sharp & Dohme LLC
$83
Medtronic, Inc.
$72
Astellas Pharma US Inc
$65
Antares Pharma, Inc.
$59
Axonics, Inc.
$42
Endo USA, Inc.
$37
Acerus Pharmaceuticals Corporation
$36
Janssen Biotech, Inc.
$36
AstraZeneca Pharmaceuticals LP
$35
Progenics Pharmaceuticals, Inc.
$28
Bayer HealthCare Pharmaceuticals Inc.
$27
Tolmar, Inc.
$26
TOLMAR Pharmaceuticals, Inc.
$24
Olympus America Inc.
$21
CIVCO Medical Instruments
$19
PROGENICS PHARMACEUTICALS, INC.
$17
Supernus Pharmaceuticals, Inc.
$17
Myovant Sciences Inc.
$17
Telix Pharmaceuticals
$16
Foundation Medicine, Inc.
$15
Mission Pharmacal Company
$14
Top 3 companies account for 41.8% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · AQUAMANTYS · AVEED · Axonics · Axumin · BOTOX · ELIGARD · ERLEADA · FOUNDATIONONE LIQUID CDX · GEMTESA · ILLUCCIX · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · NOCDURNA · Natesto · Nubeqa · OES CYSTONEPHROFIBERSCOPE · ORGOVYX · POSLUMA · PROVENGE · PYLARIFY · URIBEL · UROLIFT · XIAFLEX · XTANDI · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Raleigh?
Compare urology physicians in the Raleigh area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
82
Per 100K population
7.1
County median income
$101,763
Nearest hospital
REX HOSPITAL
2.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Teasdall is a clinical cardiology specialist, with above-average Medicare volume (top 23% in NC), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Teasdall experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Teasdall performed 1,200 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Teasdall receive payments from pharmaceutical companies?
Yes. Dr. Teasdall received a total of $2,671 from 30 companies across 121 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Teasdall's costs compare to other urology physicians in Raleigh?
Dr. Teasdall's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Teasdall) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →